Ophthalmology · Bradenton, FL
NPI
1295116242
Since 2015
Specialty
Ophthalmology
Code 207W00000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
217 Manatee Ave E
Bradenton, FL, 34208
Phone (941) 748-1818
Groups this clinician bills Medicare through
Medicare paid, 2024
$4.3M
732,530 services
Medicare patients, 2024
1,753
Average age 78
Drug cost, 2024
$470K
990 prescriptions
Company payments, 2025
$1,659
From 10 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Philip L Ames was code J2403 (chloroprocaine hcl ophthalmic, 3% gel, 1 mg), 640,000 times for 283 patients. In total Philip L Ames billed 732,530 services in 56 codes, and Medicare paid $4.3M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-11-30.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J2403 Chloroprocaine hcl ophthalmic, 3% gel, 1 mg | Office | 640,000 | 283 | $0.49 | $316K |
| J2777 Injection, faricimab-svoa, 0.1 mg | Office | 74,220 | 269 | $27.42 | $2.0M |
| J2781 Injection, pegcetacoplan, intravitreal, 1 mg | Office | 6,045 | 68 | $117.29 | $709K |
| 92134 Computerized Ophthalmic Imaging | Office | 3,457 | 1,697 | $28.03 | $97K |
| 67028 Intravitreal Injection | Office | 1,876 | 403 | $88.98 | $167K |
| J2782 Injection, avacincaptad pegol, 0.1 mg | Office | 1,700 | 24 | $85.98 | $146K |
| 92014 Ophthalmological E&M | Office | 1,214 | 1,121 | $85.15 | $103K |
| 99214 Office E&M - Established | Office | 962 | 558 | $88.70 | $85K |
| J3299 Injection, triamcinolone acetonide (xipere), 1 mg | Office | 864 | 15 | $38.04 | $33K |
| J0177 Injection, aflibercept hd, 1 mg | Office | 624 | 28 | $261.62 | $163K |
| J0178 Injection, aflibercept, 1 mg | Office | 326 | 57 | $660.03 | $215K |
| 99213 Office E&M - Established | Office | 236 | 194 | $63.20 | $15K |
| 92201 Ophthalmological E&M | Office | 210 | 164 | $17.48 | $3,672 |
| J3490 Unclassified drugs | Office | 151 | 48 | $513.95 | $78K |
| 92250 Angiography | Office | 118 | 111 | $26.59 | $3,138 |
By year: 2022 $1.8M for 12,620 services; 2023 $3.6M for 68,210 services; 2024 $4.3M for 732,530 services.
Medicare prescription drug claims, 2024
In 2024, the drug Philip L Ames prescribed most often to Medicare patients was Diclofenac Sodium, with 205 prescriptions and refills. In total Philip L Ames wrote 990 Medicare prescriptions that cost $470K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Diclofenac Sodium Generic | 205 | 319 | 99 | $2,095 |
| Prolensa Bromfenac Sodium | 110 | 137 | 27 | $42K |
| Brimonidine Tartrate Generic | 89 | 170 | 43 | $598 |
| Neomycin-Polymyxin-Dexameth Neomycin/Polymyxin B/Dexametha | 83 | 86 | 50 | $933 |
| Prednisolone Acetate Generic | 80 | 93 | 43 | $2,558 |
| Ketorolac Tromethamine Generic | 78 | 127 | 27 | $1,500 |
| Vabysmo Faricimab-Svoa | 64 | 77 | 19 | $173K |
| Difluprednate Generic | 47 | 59 | 29 | $5,061 |
| Eylea Aflibercept | 31 | 34 | 11 | $87K |
| Bromfenac Sodium Generic | 29 | 37 | 14 | $8,455 |
| Syfovre Pegcetacoplan/Pf | 28 | 30 | Under 11 | $111K |
| Loteprednol Etabonate Generic | 21 | 26 | 11 | $4,086 |
| Latanoprost Generic | 21 | 41 | Under 11 | $341 |
| Brimonidine Tartrate-Timolol Brimonidine Tartrate/Timolol | 15 | 22 | Under 11 | $1,769 |
| Dorzolamide-Timolol Dorzolamide Hcl/Timolol Maleat | 14 | 40 | Under 11 | $240 |
Brand drugs: 388 claims; generic drugs: 602 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Philip L Ames $1,659 ($1,659 in general payments such as food, travel and fees) from 10 companies. The largest payer was Astellas Pharma US Inc with $239.
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc 4503.T | 9 | $239 |
| Alcon Vision LLC ALC | 4 | $239 |
| Genentech USA, Inc. ROG.SW | 8 | $232 |
| Harrow Eye, LLC | 9 | $228 |
| Regeneron Healthcare Solutions, Inc. REGN | 6 | $204 |
| Apellis Pharmaceuticals, Inc. APLS | 7 | $189 |
| Abbvie Inc. ABBV | 6 | $152 |
| ANI Pharmaceuticals, Inc. ANIP | 5 | $121 |
| Bausch & Lomb Americas Inc. BLCO | 2 | $33.94 |
| Notal Vision, Inc. | 1 | $19.8 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.